Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66,399,673
-
Total 13F shares
-
64,917,500
-
Share change
-
-2,938,753
-
Total reported value
-
$3,634,216,597
-
Put/Call ratio
-
6%
-
Price per share
-
$55.98
-
Number of holders
-
202
-
Value change
-
-$154,967,284
-
Number of buys
-
102
-
Number of sells
-
77
Institutional Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q4 2024
As of 31 Dec 2024,
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) was held by
202 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
64,917,500 shares.
The largest 10 holders included
BlackRock, Inc., PRIMECAP MANAGEMENT CO/CA/, RA CAPITAL MANAGEMENT, L.P., BAKER BROS. ADVISORS LP, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, NEA Management Company, LLC, Frazier Life Sciences Management, L.P., STATE STREET CORP, and GOLDMAN SACHS GROUP INC.
This page lists
202
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.